SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact attorneys before the January 5, 2026, Lead Plaintiff Deadline. The lawsuit, which is currently pending in the U.S. District Court for the District of Minnesota, alleges that Inspire Medical and its executives misled i ...

SAN FRANCISCO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact its attorneys before the January 5, 2026, Lead Plaintiff Deadline. The lawsuit, which is currently pending in the U.S. District Court for the District of Minnesota, alleges that Inspire Medical and its executives misl ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - J ...

NEW YORK, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/in ...

NEW YORK, Jan. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...

诉讼概述 - 哈根斯·伯曼律师事务所提醒Inspire Medical Systems投资者注意一项待决的证券集体诉讼，该诉讼指控公司及其高管在推出新一代Inspire V设备时隐瞒了关键运营故障，误导了投资者 [1] - 诉讼待决于美国明尼苏达州地区法院，鼓励在2024年8月6日至2025年8月4日期间购买INSP证券并遭受重大损失的投资者在2026年1月5日首席原告截止日期前联系该律师事务所 [1][2] 指控核心内容 - 公司据称向投资者保证其已为Inspire V的发布做好“运营准备”，并准备好进行全面商业推广，但这些保证掩盖了使成功发布成为不可能的根本性故障，最终导致灾难性的业绩指引削减和股价暴跌 [2] - 据称被隐瞒的运营问题包括：医疗保险计费软件未就绪、旧款Inspire IV设备渠道库存过剩、以及许多治疗中心未完成新设备植入所需的必要培训与入职流程 [3] 具体指控细节 - **医疗保险与计费准备**：处理医疗保险索赔所需的软件更新直到2025年7月1日才生效，这意味着植入中心无法为手术计费，阻碍了早期采用，延迟了Inspire V的推广并阻塞了收入生成 [3] - **过剩库存（渠道积压）**：客户和治疗中心持有大量旧款Inspire IV设备库存，影响了对新款Inspire V产品的需求，需要进行库存“消化”，这导致公司将其2025年每股收益指引削减了超过80% [3] - **培训与入职**：“许多中心”尚未完成植入新设备所需的基本培训、合同签订和入职流程，这些问题导致股价每股下跌42.04美元，市值下跌32.4% [3] 调查重点与影响 - 律师事务所调查的重点据称是两点隐瞒：医疗保险索赔软件故障和旧款Inspire IV设备的库存积压，诉讼指控管理层优先考虑无缝过渡的叙事，而非运营现实，这导致了股价崩溃 [4] - 此次事件对Inspire Medical Systems的业务和股价造成了重大影响，包括Inspire V推广延迟、收入生成瓶颈、2025年每股收益指引被大幅削减超过80%，以及股价出现每股42.04美元的下跌和32.4%的价值缩水 [3][4]

New York, New York--(Newsfile Corp. - January 3, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfala ...

SAN FRANCISCO, Jan. 02, 2026 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP). The firm is urging INSP investors who suffered substantial losses to contact its attorneys before the January 5, 2026, Lead Plaintiff Deadline. The lawsuit, which is currently pending in the U.S. District Court for the District of Minnesota, alleges that Inspire Medical and its executives misl ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Jan. 02, 2026 (GLOBE NEWSWI ...

NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/in ...